The global demand for Artificial Pancreas Device Systems (APDS) Market is presumed to reach the market size of nearly USD 1482.88 MN by 2030 from USD 355.63 MN in 2022 with a CAGR of 19.54% under the study period 2023 - 2030.
An Artificial Pancreas Device System (APDS) is a medical technology designed to improve the management of diabetes. The system is also known as a closed-loop system and aims to automate and optimize the delivery of insulin to maintain blood glucose levels within a target range.
Market Dynamics
The artificial pancreas device systems (APDS) market is propelled by factors aimed at revolutionizing diabetes management. APDS, or closed-loop systems, automate insulin delivery based on real-time glucose monitoring, promising improved glycemic control and a reduced burden of daily diabetes management. This technology minimizes the risk of hypoglycemia and hyperglycemia, offering convenience and enhancing the quality of life for individuals with diabetes. Technological advancements in sensor technology, control algorithms, and insulin pump design contribute to the continuous evolution of APDS, making them more accurate, responsive, and user-friendly. The global rise in diabetes prevalence, coupled with government support and regulatory approvals, creates a growing market for these innovative solutions. Patient preferences for wearable devices and a broader focus on outcomes-based healthcare further drive the adoption of APDS. Research and development investments, coupled with awareness and education initiatives, play pivotal roles in shaping the trajectory of the APDS market, which continues to advance as a promising avenue for effective and automated diabetes management.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial pancreas device systems (apds). The growth and trends of artificial pancreas device systems (apds) industry provide a holistic approach to this study.
Market Segmentation
This section of the artificial pancreas device systems (apds) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Device Type
- Threshold Suspend Device Systems
- Control-To-Range (CTR) Systems
- Control-To-Target (CTT) Systems
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Artificial Pancreas Device Systems (APDS) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Artificial Pancreas Device Systems (APDS) Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Artificial Pancreas Device Systems (APDS) market include GE Healthcare, Philips, SunTech Medical Inc., Omron Healthcare Inc., Spacelabs Healthcare Inc., American Diagnostic Corporation, Hill-Rom Services, Midmark, Cardinal Health, Medline Industries. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.